Get the Stockscreener App
1.38
1.88%
-0.0265
Estrella Immunopharma Inc Stock (ESLA) Forecast
The Estrella Immunopharma Inc (ESLA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.3697, representing a +144.18% increase from the current price of $1.38. The highest analyst price target is $3.7095, and the lowest is $3.03.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ESLA Price Target
Average 3.2361
(+134.50% Upside)
Is Estrella Immunopharma Inc (ESLA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.17 | Neutral |
| STOCH(9,6) | 18.71 | Buy |
| STOCHRSI(14) | 9.6664 | Buy |
| MACD(12,26) | 0.04 | Sell |
| ADX(14) | 28.00 | Buy |
| William %R | -97.11 | Buy |
| CCI(14) | -88.70 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.5977
Sell
|
1.5755
Sell
|
| MA20 |
1.6963
Sell
|
1.5698
Sell
|
| MA50 |
1.3622
Buy
|
1.4588
Sell
|
| MA100 |
1.3387
Buy
|
1.4159
Sell
|
| MA200 |
1.4026
Buy
|
1.3657
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, ESLA could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on ESLA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 44.17 indicates that ESLA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.71 indicates that ESLA is oversold. This indicates that ESLA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.6664 indicates that ESLA is oversold. This suggests that ESLA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.7 indicates that ESLA is still oversold but not to an extreme extent.
Long-term ESLA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Estrella Immunopharma Inc financial reports and earnings history, Estrella Immunopharma Inc (ESLA) stock could reach $9.5269 by 2030, $17.93 by 2040 and $44.64 by 2050. See the projected annual prices until 2050 of the Estrella Immunopharma Inc stock below:
- Estrella Immunopharma Inc (ESLA) is expected to reach an average price of $13.71 in 2035, with a high prediction of $15.05 and a low estimate of $13.82. This indicates an $893.34% rise from the last recorded price of $1.38.
- Estrella Immunopharma Inc (ESLA) stock is projected to chart a bullish course in 2040, with an average price target of $16.40, representing an $1,088% surge from its current level. The forecast ranges from a conservative $16.52 to a sky-high $17.93.
- Our analysts predict Estrella Immunopharma Inc (ESLA) to jump 2,799% by 2045, soaring from $17.41 to an average price of $40.01, potentially reaching $39.11. While $17.41 is the low estimate, the potential upside is significant.
- Estrella Immunopharma Inc (ESLA) stock is expected to climb by 2050, reaching an average of $42.13, a $2,953% jump from its current level. However, a wide range of estimates exists, with high and low targets of $44.64 and $42.13, respectively, highlighting the market's uncertainty.
Estrella Immunopharma Inc Stock (ESLA) Year by Year Forecast
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2026
The predicted value for Estrella Immunopharma Inc (ESLA) in 2026 is set at an average of $2.2705. Estimates vary from a peak of $3.7095 to a trough of $0.8315, indicating an +64.53% surge from the present price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $3.5242 | $3.03 | $3.7095 | +155.38% |
| July, 2026 | $3.3478 | $3.5478 | $3.4731 | +142.59% |
| August, 2026 | $3.1567 | $3.1373 | $2.942 | +128.75% |
| September, 2026 | $2.7303 | $2.9903 | $3.0314 | +97.85% |
| October, 2026 | $2.4892 | $2.6145 | $2.5551 | +80.38% |
| November, 2026 | $2.2431 | $2.2881 | $2.3053 | +62.55% |
| December, 2026 | $1.7318 | $1.8118 | $2.0229 | +25.49% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Estrella Immunopharma Inc (ESLA) is $3.8948, with a high forecast of $6.3442 and a low forecast of $1.4454. This indicates an +182.23% increase from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4908 | $1.5307 | $1.5866 | +8.03% |
| February, 2027 | $5.2106 | $1.4454 | $5.0268 | +277.58% |
| March, 2027 | $4.8037 | $4.8538 | $4.6838 | +248.10% |
| April, 2027 | $4.3475 | $4.2841 | $4.1773 | +215.03% |
| May, 2027 | $4.1011 | $4.1011 | $4.1143 | +197.18% |
| June, 2027 | $3.4381 | $3.5481 | $3.8445 | +149.14% |
| July, 2027 | $3.2218 | $3.2318 | $3.3115 | +133.46% |
| August, 2027 | $2.6654 | $2.7871 | $3.0452 | +93.14% |
| September, 2027 | $2.2624 | $2.2624 | $2.4488 | +63.94% |
| October, 2027 | $6.5421 | $2.0592 | $5.6421 | +374.06% |
| November, 2027 | $5.9904 | $6.1104 | $6.3442 | +334.09% |
| December, 2027 | $5.4309 | $5.4309 | $5.8946 | +293.54% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2028
In 2028, Estrella Immunopharma Inc (ESLA) is projected to reach an average price of $5.1673, with a high projection of $7.6615 and a low estimate of $2.6731. This indicates an +274.44% rise from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.2592 | $5.2693 | $5.1972 | +281.10% |
| February, 2028 | $4.6375 | $4.7576 | $5.0313 | +236.05% |
| March, 2028 | $4.208 | $4.208 | $4.4497 | +204.93% |
| April, 2028 | $3.5964 | $3.7464 | $3.927 | +160.61% |
| May, 2028 | $2.9968 | $3.0768 | $3.3333 | +117.16% |
| June, 2028 | $7.11 | $2.6731 | $6.02 | +415.22% |
| July, 2028 | $7.3231 | $7.4178 | $7.6615 | +430.66% |
| August, 2028 | $6.5169 | $6.8669 | $7.1238 | +372.24% |
| September, 2028 | $6.37 | $6.43 | $6.3185 | +361.59% |
| October, 2028 | $5.7231 | $5.9831 | $6.1608 | +314.72% |
| November, 2028 | $5.1369 | $5.1869 | $5.4839 | +272.24% |
| December, 2028 | $4.60 | $4.7692 | $4.9143 | +233.33% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2029
The 2029 price forecast for Estrella Immunopharma Inc Stock (ESLA) is $6.7916 on average, with a high prediction of $10.30 and a low estimate of $3.2869. This represents an +392.15% increase from the previous price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.764 | $3.8339 | $4.0964 | +172.75% |
| February, 2029 | $3.4058 | $3.2869 | $3.5247 | +146.80% |
| March, 2029 | $8.7084 | $8.47 | $8.9789 | +531.04% |
| April, 2029 | $8.4361 | $8.4862 | $8.3778 | +511.31% |
| May, 2029 | $7.5734 | $7.6334 | $7.7456 | +448.80% |
| June, 2029 | $6.9213 | $7.2218 | $7.3629 | +401.55% |
| July, 2029 | $6.239 | $6.349 | $6.6707 | +352.10% |
| August, 2029 | $5.5513 | $5.5963 | $6.0485 | +302.27% |
| September, 2029 | $4.6941 | $4.8541 | $5.2457 | +240.15% |
| October, 2029 | $4.0314 | $4.0713 | $4.4535 | +192.13% |
| November, 2029 | $10.48 | $3.9008 | $10.30 | +659.43% |
| December, 2029 | $9.7972 | $9.8088 | $9.7844 | +609.94% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2030
Estrella Immunopharma Inc Stock (ESLA) is expected to reach an average price of $8.0641 in 2030, with a high forecast of $11.61 and a low forecast of $4.5146. This signifies an +484.36% surge from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.8495 | $8.8713 | $9.5269 | +541.27% |
| February, 2030 | $8.262 | $8.262 | $8.4457 | +498.70% |
| March, 2030 | $7.4745 | $7.5145 | $7.9201 | +441.63% |
| April, 2030 | $6.8171 | $6.8171 | $7.0127 | +393.99% |
| May, 2030 | $5.7177 | $5.8394 | $6.4721 | +314.33% |
| June, 2030 | $5.0302 | $5.1102 | $5.4159 | +264.51% |
| July, 2030 | $11.90 | $4.5146 | $11.00 | +762.09% |
| August, 2030 | $11.00 | $11.12 | $11.61 | +697.40% |
| September, 2030 | $10.02 | $10.37 | $10.74 | +626.18% |
| October, 2030 | $9.5054 | $9.5155 | $9.7481 | +588.80% |
| November, 2030 | $8.5426 | $8.6627 | $9.1922 | +519.03% |
| December, 2030 | $7.8099 | $7.8599 | $8.2695 | +465.94% |
0.78%
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):